Trazimera – Trastuzumab uses, dose and side effects
Trazimera contains the active ingredient trastuzumab, which is a monoclonal antibody . Monoclonal antibodies attach to specific proteins or antigens . Trastuzumab is designed to bind selectively to an antigen called human epidermal growth factor receptor 2 ( HER2 ). HER2 is found in large quantities on the surface of certain cancer cells and then stimulates cell growth. When Trazimera binds to HER2 , the growth of the cancer cells is stopped and this leads to their death.
Read More